![Laura Aguilar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Laura Aguilar
No open positions remaining
Net worth: 22 M $ as of 2026-07-30
Profile
Laura K.
Aguilar served as the Chief Medical Officer at Candel Therapeutics, Inc. from 2014 to 2022.
Prior to that, she worked at the same company from 2006.
Aguilar received her undergraduate degree from the University of California, Davis and her doctorate from Baylor College of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-23 | 2,193,961 ( 2.99% ) | 22 M $ | 2026-07-30 |
Former positions of Laura Aguilar
| Companies | Position | End |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-02-06 |
Training of Laura Aguilar
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
20
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Candel Therapeutics, Inc.
 Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
- Stock Market
- Insiders
- Laura Aguilar
